INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candida | INO Message Board Posts


Inovio Biomedical Corporation

  INO website

INO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  2135 of 2142  at  8/28/2021 1:04:45 PM  by

co3aii

The following message was updated on 8/28/2021 1:06:13 PM.

 In response to msg 2134 by  billmax
view thread

Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

The late, great,  Charles McGolrick who taught us, would constantly say when people would indicate  that they did not sell at the top, "No one ever went broke taking a profit."  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
2137 Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 no_gluts_no_gory 1 9/1/2021 9:20:27 PM


Financial Market Data provided by
.
Loading...